A Prospective Randomized Placebo-controlled Study of the Effect of Eplerenone on Left Ventricular Diastolic Function in Women Receiving Anthracycline Therapy for Breast Cancer
Phase of Trial: Phase II/III
Latest Information Update: 09 Jan 2017
At a glance
- Drugs Eplerenone (Primary)
- Indications Heart failure
- Focus Pharmacodynamics
- 03 Jan 2017 Status changed from not yet recruiting to discontinued due to Futility.
- 11 Jun 2014 Planned End Date changed from 1 Oct 2015 to 1 May 2015 as reported by ClinicalTrials.gov.
- 05 Nov 2013 Company added as trial sponsor and additional lead trial centre identified as reported by ClinicalTrials.gov.